Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
polycystin 2, transient receptor potential cation channel | 0.552 | 0.731 | 1.7E-04 |
|
disease | 1.000 | definitive | 0.984 | 312 | 18 | 1994 | 2020 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
disease | 0.900 | definitive | 0.979 | 429 | 2 | 1988 | 2020 | ||||||||
|
glucosidase II alpha subunit | 0.716 | 0.423 | 1.00 |
|
disease | 0.640 | None | 1.000 | 4 | 1 | 2016 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2010 | 2018 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 6 | 0.682 | 0.346 | 6.9E-06 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 1997 | 2002 | ||||||||
|
BicC family RNA binding protein 1 | 0.636 | 0.577 | 0.84 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2012 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ALG9 alpha-1,2-mannosyltransferase | 0.644 | 0.654 | 6.4E-04 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
kinesin family member 3A | 0.612 | 0.615 | 0.90 |
|
disease | 0.200 | None | 0 | 0 | |||||||||||
|
protein kinase D1 | 0.531 | 0.846 | 6.6E-07 |
|
disease | 0.100 | None | 0.974 | 38 | 0 | 1990 | 2019 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.100 | None | 0.941 | 17 | 1 | 1990 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.100 | None | 0.824 | 17 | 2 | 1997 | 2017 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1994 | 2015 | ||||||||
|
arginine vasopressin receptor 2 | 0.568 | 0.769 | 0.56 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2016 | 2019 | ||||||||
|
hemoglobin subunit alpha 1 | 0.508 | 0.808 | 6.7E-03 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1985 | 1992 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2008 | 2019 | ||||||||
|
hemoglobin subunit alpha 2 | 0.512 | 0.808 | 3.1E-03 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1985 | 1992 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1996 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.090 | None | 0.889 | 9 | 1 | 2002 | 2014 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2010 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.070 | None | 1.000 | 7 | 3 | 1997 | 2017 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 | ||||||||
|
fibroblast growth factor 23 | 0.460 | 0.731 | 3.1E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2012 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 |